It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The Apolipoprotein E (APOE) gene polymorphism (rs429358 and rs7412) shows a well-established association with lipid profiles, but its effect on cardiovascular disease is still conflicting. Therefore, we examined the association of different APOE alleles with common carotid artery intima-media thickness (CCA-IMT), carotid plaques, incident myocardial infarction (MI) and stroke. We analyzed data from 3327 participants aged 20–79 years of the population-based Study of Health in Pomerania (SHIP) from Northeast Germany with a median follow-up time of 14.5 years. Linear, logistic, and Cox-regression models were used to assess the associations of the APOE polymorphism with CCA-IMT, carotid plaques, incident MI and stroke, respectively. In our study, the APOE E2 allele was associated with lower CCA-IMT at baseline compared to E3 homozygotes (β: − 0.02 [95% CI − 0.04, − 0.004]). Over the follow-up, 244 MI events and 218 stroke events were observed. APOE E2 and E4 allele were not associated with incident MI (E2 HR: 1.06 [95% CI 0.68, 1.66]; E4 HR: 1.03 [95% CI 0.73, 1.45]) and incident stroke (E2 HR: 0.79 [95% CI 0.48, 1.30]; E4 HR: 0.96 [95% CI 0.66, 1.38]) in any of the models adjusting for potential confounders. However, the positive association between CCA-IMT and incident MI was more pronounced in E2 carriers than E3 homozygotes. Thus, our study suggests that while APOE E2 allele may predispose individuals to lower CCA-IMT, E2 carriers may be more prone to MI than E3 homozygotes as the CCA-IMT increases. APOE E4 allele had no effect on CCA-IMT, plaques, MI or stroke.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University Medicine Greifswald, SHIP/Clinical-Epidemiological Research, Institute for Community Medicine, Greifswald, Germany (GRID:grid.5603.0)
2 University Medicine Greifswald, Department of Internal Medicine B, Greifswald, Germany (GRID:grid.5603.0); German Center for Cardiovascular Research (DZHK E.V.), Partner site Greifswald, Greifswald, Germany (GRID:grid.452396.f) (ISNI:0000 0004 5937 5237); DZD (German Center for Diabetes Research), Site Greifswald, Greifswald, Germany (GRID:grid.452396.f)
3 University Medicine Greifswald, SHIP/Clinical-Epidemiological Research, Institute for Community Medicine, Greifswald, Germany (GRID:grid.5603.0); University Medicine Greifswald, Department of Medicine A, Greifswald, Germany (GRID:grid.5603.0)
4 University Medicine Greifswald, SHIP/Clinical-Epidemiological Research, Institute for Community Medicine, Greifswald, Germany (GRID:grid.5603.0); German Center for Cardiovascular Research (DZHK E.V.), Partner site Greifswald, Greifswald, Germany (GRID:grid.452396.f) (ISNI:0000 0004 5937 5237)
5 University Medicine Greifswald, Department of Psychiatry and Psychotherapy, Greifswald, Germany (GRID:grid.5603.0); German Center for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, Greifswald, Germany (GRID:grid.424247.3) (ISNI:0000 0004 0438 0426)
6 German Center for Cardiovascular Research (DZHK E.V.), Partner site Greifswald, Greifswald, Germany (GRID:grid.452396.f) (ISNI:0000 0004 5937 5237); University Medicine Greifswald, Institute of Clinical Chemistry and Laboratory Medicine, Greifswald, Germany (GRID:grid.5603.0)
7 University Medicine Greifswald, Department of Internal Medicine B, Greifswald, Germany (GRID:grid.5603.0); German Center for Cardiovascular Research (DZHK E.V.), Partner site Greifswald, Greifswald, Germany (GRID:grid.452396.f) (ISNI:0000 0004 5937 5237)
8 University Medicine Greifswald, SHIP/Clinical-Epidemiological Research, Institute for Community Medicine, Greifswald, Germany (GRID:grid.5603.0); German Center for Cardiovascular Research (DZHK E.V.), Partner site Greifswald, Greifswald, Germany (GRID:grid.452396.f) (ISNI:0000 0004 5937 5237); DZD (German Center for Diabetes Research), Site Greifswald, Greifswald, Germany (GRID:grid.452396.f)